
IV Therapy Compliance in 2026: What State Boards Changed, What's Only Newly Enforced, and What It Means for Your Clinic
If you run an IV therapy or drip-bar business, or you're thinking about adding one, 2026 has probably felt like a barrage of state board activity. Kansas issued a joint statement in February. Georgia issued a position statement in May that set off protests near the state Capitol. West Virginia followed with a 21-point joint advisory opinion in July, and Maine adopted a binding joint rule the same month. California's pharmacy board, meanwhile, has been telling IV clinics that compounding inspections are coming.
Most of what circulates online lumps all of this into one "crackdown." That framing is incomplete, and it leads clinics to the wrong fixes. Some of this is genuinely new rulemaking. More of it is existing law being pointed at retail clinics. This guide walks through five states, Georgia, West Virginia, Maine, Kansas and California, then gives you the common checklist to audit against wherever you operate.

Quick answer
The boards in these five states take a similar line: IV therapy is the practice of medicine, so it needs a real prescriber-patient relationship and an individualized order, not a standing order or a self-select menu. Unlicensed staff cannot examine, prescribe or administer, and compounding carries its own rules. Details and legal weight differ by state, so check each source below.
What actually changed in 2026: new law vs. newly enforced law
According to Holt Law, a health-law firm, elective IV therapy is regulated as the practice of medicine in essentially every state, and 2026 has brought both genuinely new law and stepped-up enforcement of existing standards.
Compounding is the most commonly misunderstood piece. Holt reports that the four-hour "immediate use" window under United States Pharmacopeia (USP) Chapter 797 was announced in November 2022 and took effect November 1, 2023, replacing the prior one-hour exemption. It is not a 2026 rule. What has changed, per Holt, is enforcement against retail clinics. Maine's rule says some IV businesses have been "misinterpreting the concept of 'immediate use'" to justify skipping sterile preparation.
One piece of genuinely new law is worth naming for Texas clinicians. According to Holt, Texas House Bill 3749, known as "Jenifer's Law," was signed June 20, 2025 and took effect September 1, 2025, after a patient died following an IV infusion from an unlicensed individual at a Texas med spa. We covered Texas in our IV certification post and the fundamentals of launching an IV service in our 2026 clinician guide, so we won't repeat them here.
Georgia: the position statement that started a fight
On May 7, 2026, the Georgia Composite Medical Board issued an IV Hydration/Therapy Position Statement covering delegating physician-APRN relationships, supervision for IV hydration, and PA-supervising physician relationships. The board said it generally evaluates physician-APRN arrangements by "the substance & practical effect of the relationship" rather than formal structure, title or contract wording.
Three points carry real consequence for clinic owners:
A physician may delegate to an APRN only if the APRN is fully licensed, the APRN's specialty is comparable to the physician's, and the parties keep a compliant nurse protocol agreement.
Under O.C.G.A. § 43-34-25(n), it is unlawful for a physician to be an employee of an APRN if the physician must supervise that APRN. The board said it has not limited "employee" to W-2 versus 1099 status and reads the prohibition to cover compensation of any kind for the supervising or delegating role.
Third-party matching companies do not cure the problem. The board named "Collaborating MD's/DO's," "APRNMatch," and "NP Collaborator" as examples and said it would view an arrangement as prohibited where the APRN, in substance, directly or indirectly pays the delegating physician through the third party.
On the IV side, the statement relays the Georgia Board of Nursing's position: RNs or LPNs may administer IV hydration, nutrient therapies and medications under supervision only with a valid individualized order from a physician, NP or PA, plus a completed history and physical. Standing orders are "not an appropriate substitute." In walk-in clinics, mobile hydration clinics and drip bars, an RN or LPN may not be the only licensed professional evaluating and treating the patient. The statement also says a clinic should not rely on "RN/LPN-only evaluation, generic standing orders, menu-based treatment without individualized assessment," or sterile compounding that fails Georgia pharmacy law and USP 797 where applicable.
The reaction was fast. The Georgia Nurses Association said on May 28 that it was "deeply disappointed" and argued the position could strain the workforce and reduce access, particularly in rural and underserved communities. The Atlanta Journal-Constitution reported that APRNs gathered outside the state Capitol to voice concerns. On June 5 the board posted a follow-up statement and a document titled "Misinformation the Board Would Like to Address." The position statement is the board's reading of existing law, not a new regulation, but it tells you where scrutiny is headed.
West Virginia: a 21-point joint advisory opinion
On July 8, 2026, the West Virginia Board of Medicine, Board of Osteopathic Medicine and Board of Pharmacy issued a Joint Advisory Opinion on retail IV therapy, updated July 13. It is an advisory opinion, not a regulation, and it sets out 21 best-practice points. Its positions:
IV therapy, including IV hydration, is the practice of medicine, and a provider-patient relationship comes first.
Physicians may assess patients for IV therapy; PAs and APRNs may do so within their education, training, experience and scope.
IV saline and all additives are drugs requiring a prescription or order.
Physicians, PAs and APRNs "should not issue 'standing orders' for a retail IV therapy business, or its employees."
IV cocktails are compounded drugs, and compounding should follow USP 797 standards for immediate-use compounds only.
The opinion lists prescription drugs such as Pepcid, Toradol and Zofran among typical additives, alongside amino acids, vitamins and minerals.
One staffing nuance: the on-site presence of a physician, PA or APRN is not required for an RN to administer an ordered IV, but the RN must have the knowledge, skill and competency to monitor the patient safely. Prescribers may not delegate to RNs the authority to prescribe or order IV therapy, approve a patient's cocktail "selection," give IV therapy without a valid order, or compound cocktails.
Maine: a binding joint rule
Maine went further than advisory guidance. Chapter 15, the Joint Rule Regarding Standards of Practice for IV Therapy Businesses, Medical Spas and Medical Aesthetic Businesses, took effect July 14, 2026. It is a joint rule of the Board of Licensure in Medicine, the State Board of Nursing and the Board of Osteopathic Licensure, and violating it is unprofessional conduct and grounds for discipline.
From the rule text:
Only physicians, physician associates and APRNs with prescriptive authority can evaluate the patient, diagnose and prescribe, and that authority cannot be delegated to anyone without it, including an RN.
A physician, PA or APRN may own or be medical director of an IV business, but that role alone does not establish the licensee-patient relationship needed before prescribing.
A static internet questionnaire does not count as an acceptable clinical interview and exam. Telehealth can qualify only if it is sufficient to support an informed diagnosis as though performed in person.
Using standing orders for individualized assessment, diagnosis and treatment is unprofessional conduct.
Administration of IV saline, with or without additives, "must result from a valid physician, physician associate, or advanced practice registered nurse order" and not from "a patient-driven menu."
In a clinic or office setting, a licensed physician must perform compounding, and not in response to a patient's selection from a menu.
Walk-in, mobile or concierge IV services do not fall under the USP 797 "immediate use" exception.
When prescribing a drug on the FDA shortage list for elective or nonmedical use, the prescriber must document support in the patient's record.
According to AmSpa general counsel Patrick O'Brien, JD, the rule also bars medical assistants from examination, assessment, diagnosis, prescription or administration of medications. The drug-shortage point matters for clinics marketing "wellness" IVs built around a scarce drug.

Kansas: enforcement priorities on menus and compounding
On February 25, 2026, the Kansas State Board of Healing Arts and Board of Pharmacy issued a joint statement in response to complaints about retail IV clinics. It is not a binding regulation, and it signals enforcement priorities. According to the boards' statement, as reported by the law firm Seigfreid Bingham and AmSpa:
Providing IV therapy "indisputably constitutes the practice of healing arts."
A patient may not self-prescribe IV products, and pre-set cocktail menus are viewed as non-compliant.
Non-patient-specific standing orders do not constitute valid prescriptions, because a blanket order cannot reflect a patient-specific assessment.
Adding substances to a saline bag is drug compounding subject to pharmacy law. AmSpa reports the statement says cosmetologists, estheticians and unlicensed persons may not mix additives into saline.
The compounding point is the one most clinics underweight: on-site bag preparation without a pharmacist or physician performing or supervising it carries independent exposure.
California: ownership, corporate practice and compounding
California is where enforcement meets ownership structure. Two caveats first. The California sources here are narrower than the others, and the pharmacy board's guidance dates to 2024, not 2026.
According to Holt Law, California's corporate-practice doctrine means a licensed physician must hold controlling ownership and voting interest in the clinical entity, commonly described as 51% physician and 49% other licensed professionals. Holt also reports that SB 351, signed October 6, 2025 and effective January 1, 2026, codifies the corporate practice doctrine against management companies, private equity groups and hedge funds directing clinical decisions, and that conflicting provisions in existing management agreements became void January 1, 2026. A companion law, AB 1415, adds a 90-day pre-transaction notice to the Office of Health Care Affordability for many healthcare transactions. Check the chaptered bills with counsel before relying on these summaries.
On compounding, the California State Board of Pharmacy's "Education for All Compounders," approved August 1, 2024, says board inspections of some retail IV locations "have revealed violations," including purchasing products from unlicensed sources and compounding violations. It notes that FDA says "compounded drugs are not FDA-approved," that sterile compounding must comply with USP Chapter 797 (nonsterile with Chapter 795), and that USP standards "DO NOT establish authority to compound." The board says it will conduct inspections where drugs are compounded, prepared, furnished, dispensed or stored. The document does not address standing orders or menus.
The common thread: what to audit in your clinic
Here is what each source supports, and where it is silent.
Requirement | Georgia | West Virginia | Maine | Kansas | California |
|---|---|---|---|---|---|
Position or rule that IV therapy needs licensed prescriber evaluation | Yes | Yes | Yes | Yes | Not addressed |
Standing orders rejected | Yes | Yes | Yes | Yes | Not addressed |
Self-select menus rejected | Yes | Partly (RNs may not approve a patient's "selection") | Yes | Yes | Not addressed |
Unlicensed staff barred from key tasks | Not addressed | Not addressed | Yes | Yes | Not addressed |
Compounding/USP 797 addressed | Yes | Yes | Yes | Yes (pharmacy law) | Yes |
Legal weight differs: Maine's is a rule, while Georgia, West Virginia and Kansas are position statements or advisory opinions and California's pharmacy document is educational guidance.
A real prescriber-patient relationship first. Before any IV is hung, a physician, PA or APRN should examine and diagnose. Maine's rule says a static questionnaire does not do it.
An individualized order, not a standing order. Georgia, West Virginia, Maine and Kansas all reject standing orders as a substitute.
No self-service menus. Georgia, Maine and Kansas say menu-based treatment is not acceptable, and West Virginia bars RNs from approving a patient's cocktail selection.
Licensed staff doing licensed work. Maine says unlicensed personnel may not be delegated examination, assessment, diagnosis, prescription or administration of medications, and Kansas says unlicensed persons may not mix additives.
Treat compounding as compounding. Mixing additives into saline is compounding in West Virginia, Kansas and Maine's framework. Anyone who compounds must follow the applicable USP chapters and confirm authority under state law.

Frequently asked questions
Is IV therapy the practice of medicine? Per the boards and Holt Law, yes in the states covered here and in essentially every state. Kansas's boards say IV therapy "indisputably constitutes the practice of healing arts."
Can an RN open and run an IV clinic alone? Generally not. Georgia's statement says an RN or LPN may not be the only licensed professional evaluating and treating patients in a walk-in, mobile or drip-bar setting. Maine's rule requires a physician, PA or APRN to examine, diagnose and authorize the IV preparation.
Are standing orders legal for IV therapy? Treat them as a serious risk. Maine's rule calls them unprofessional conduct for individualized care. West Virginia's opinion says prescribers should not issue them to retail IV businesses. Kansas says they are not valid prescriptions, and Georgia says they are not an appropriate substitute for an individualized order.
Can patients pick their own IV from a menu? Not safely. Kansas says patients may not self-prescribe, Maine's rule requires orders that do not come from a patient-driven menu, and West Virginia bars RNs from approving a patient's selection.
Do I need a physician medical director? It depends on your state and structure. Maine says a medical director or ownership role alone does not establish the patient relationship. California requires controlling physician ownership, according to Holt Law. Confirm your own state's rules rather than copying a national summary.
Is USP 797's four-hour immediate-use rule new? No. Holt reports it was announced in November 2022 and took effect November 1, 2023. What has changed is attention to retail clinics.
Can the patient exam be done by telemedicine? In Maine, yes, if the technology supports an informed diagnosis as though done in person. A static questionnaire is not enough.
Who can compound IV cocktails? Only people legally authorized to compound. Maine requires a licensed physician to perform compounding in a clinic setting, and West Virginia says prescribers may not delegate compounding to RNs.
The Bottom Line
The 2026 IV enforcement wave is real, but it is less a burst of new rules than boards applying long-standing principles to retail clinics. If your clinic already runs on a genuine prescriber-patient relationship, individualized orders, licensed-only clinical work and compliant compounding, most of this will not change your operations. If not, these boards have told you what they are looking at.
Ready to go from IV interest to IV service owner? The IV Therapy Course covers the clinical and operational requirements for running a licensed, defensible IV service. Or start with the free peptide training to apply the same compliance-first approach to other cash-pay lines.
This article is for educational purposes for licensed healthcare professionals and is not legal advice. Scope of practice and IV therapy rules vary by state; confirm requirements with your licensing board and health-law counsel.
Sources
IV Hydration Clinics in 2026: Separating the New Law From the Newly Enforced Law — Holt Law, April 2026
Chapter 15: Joint Rule Regarding Standards of Practice for IV Therapy Businesses, Medical Spas and Medical Aesthetic Businesses — Maine boards, effective July 2026
New IV Rules in Maine — AmSpa, July 2026
Joint Advisory Opinion Regarding Retail IV Therapy — West Virginia boards, July 2026
IV Hydration/Therapy Position Statement — Georgia Composite Medical Board, May 2026
GCMB Statement Regarding IV Hydration/Therapy Position Statement — Georgia Composite Medical Board, June 2026
Nurses concerned about Georgia medical board's announcement on IV clinics — Atlanta Journal-Constitution, June 2026
Statement regarding the Georgia Composite Medical Board position on IV Hydration Therapy — Georgia Nurses Association, May 2026
Kansas State Board of Healing Arts and Board of Pharmacy Joint Statement Regarding IV Therapy — Kansas boards, February 2026
Kansas State Board of Healing Arts and Board of Pharmacy Issue Joint Statement — Seigfreid Bingham, March 2026
Kansas Boards of Pharmacy, Healing Arts Release Joint Statement Regarding IV Therapy — AmSpa, 2026
Education for All Compounders — California State Board of Pharmacy, August 2024